This site is intended for health professionals only

Targeted Anticancer Therapies 2013


The provisional meeting schedule is online now, including keynote and session themes:
  • New immune checkpoints as drug targets
  • Phase 1 studies, completed or in progress
  • Whole-genome sequencing in early-phase development
  • Metabolic targets
  • Immunoconjugates for cancer therapy
  • Emerging new drugs and targets in hemato-oncology
  • Drugs targeting the RAS/RAF/MEK pathway
  • Preclinical models in drug discovery and development
A new element is the special biotech event, which will feature biotechs’ innovations in oncology. It will provide delegates a great view of the innovations (small) biotech companies are bringing to cancer patient management It will offer excellent business-to-business networking opportunities between biotech companies and academic investigators as well as biotech and pharma representatives.

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine